Sanfilippo Syndrome: The Tale of a Challenging Diagnosis
Abstract Sanfilippo syndrome or mucopolysaccharidosis III (MPS III), includes a group of four autosomal recessive lysosomal storage disorders caused by deficient activity of enzymes involved in the catabolism of heparan sulfate. The four types of MPS III are recognized in accordance with the deficie...
Main Authors: | Giulianna Baldini, José Fernando Palmejiani, João Pedro Bonevechio Sant'Anna, Zumira Aparecida Carneiro, Roberto Giugliani, Catarina Pereira, Claudia Cozma, Cara O’Neill, Charles M. Lourenco |
---|---|
Format: | Article |
Language: | English |
Published: |
SciELO
2020-10-01
|
Series: | Journal of Inborn Errors of Metabolism and Screening |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2326-45942020000100503&tlng=en |
Similar Items
-
Disease progression in Sanfilippo type B: Case series of Brazilian patients
by: Yorran Hardman Araújo Montenegro, et al.
Published: (2024-03-01) -
An Engineered <i>sgsh</i> Mutant Zebrafish Recapitulates Molecular and Behavioural Pathobiology of Sanfilippo Syndrome A/MPS IIIA
by: Alon M. Douek, et al.
Published: (2021-05-01) -
Sanfilippo Syndrome: Molecular Basis, Disease Models and Therapeutic Approaches
by: Noelia Benetó, et al.
Published: (2020-10-01) -
Clearance of Heparan Sulfate and Attenuation of CNS Pathology by Intracerebroventricular BMN 250 in Sanfilippo Type B Mice
by: Mika Aoyagi-Scharber, et al.
Published: (2017-09-01) -
Sanfilippo syndrome: consensus guidelines for clinical care
by: Nicole Muschol, et al.
Published: (2022-10-01)